Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chung

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
Current Oncology (Toronto, Ont.)|February 24, 2021
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular CancerDomen Ribnikar, Igor Stukalin, Philippe L Bedard, et al.
European Urology|August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular CancerMadhur Nayan, Michael A S Jewett, Ali Hosni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 25, 2020
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of lifeNoelia Sanmamed, Jenny Lee, Alejandro Berlin, et al.
Oral Oncology|August 12, 2017
Outcome following radiotherapy for head and neck basal cell carcinoma with 'aggressive' featuresAnupam Rishi, Shao Hui Huang, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 8, 2025
Clinical Outcomes of Stage IIA/IIB Seminoma Treated With Radiation Therapy and Chemotherapy: Should Regional Therapy be Considered the Preferred Treatment Approach?Rachel M Glicksman, Di Maria Jiang, Philippe L Bedard, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 6, 2024
2024 CUA-GUMOC Expert Report: Management of unresectable locally advanced and metastatic urothelial carcinomaCarlos E Stecca, Deepro Chowdhury, Normand Blais, et al.
Nature Medicine|June 4, 2021
Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancerChris McIntosh, Leigh Conroy, Michael C Tjong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 2026
Integrity of delivered dose in temporally fractionated lattice Radiotherapy amid anatomical changes and setup uncertaintiesNaiyuan Liu, Amy Parent, Yat Tsang, et al.
Urologic Oncology|June 17, 2021
Characterization and management of NMIBC recurrences after TMT: a matched cohort analysisKhaled Ajib, Mohamad Baker Berjaoui, JaimeOmar Herrera-Caceres, et al.
Clinical and Translational Radiation Oncology|November 29, 2021
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRIWei Liu, Hatim Fakir, Gurpreet Randhawa, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Current Oncology (Toronto, Ont.)|February 24, 2021
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular CancerDomen Ribnikar, Igor Stukalin, Philippe L Bedard, et al.
European Urology|August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular CancerMadhur Nayan, Michael A S Jewett, Ali Hosni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 25, 2020
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of lifeNoelia Sanmamed, Jenny Lee, Alejandro Berlin, et al.
Oral Oncology|August 12, 2017
Outcome following radiotherapy for head and neck basal cell carcinoma with 'aggressive' featuresAnupam Rishi, Shao Hui Huang, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 8, 2025
Clinical Outcomes of Stage IIA/IIB Seminoma Treated With Radiation Therapy and Chemotherapy: Should Regional Therapy be Considered the Preferred Treatment Approach?Rachel M Glicksman, Di Maria Jiang, Philippe L Bedard, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 6, 2024
2024 CUA-GUMOC Expert Report: Management of unresectable locally advanced and metastatic urothelial carcinomaCarlos E Stecca, Deepro Chowdhury, Normand Blais, et al.
Nature Medicine|June 4, 2021
Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancerChris McIntosh, Leigh Conroy, Michael C Tjong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 2026
Integrity of delivered dose in temporally fractionated lattice Radiotherapy amid anatomical changes and setup uncertaintiesNaiyuan Liu, Amy Parent, Yat Tsang, et al.
Urologic Oncology|June 17, 2021
Characterization and management of NMIBC recurrences after TMT: a matched cohort analysisKhaled Ajib, Mohamad Baker Berjaoui, JaimeOmar Herrera-Caceres, et al.
Clinical and Translational Radiation Oncology|November 29, 2021
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRIWei Liu, Hatim Fakir, Gurpreet Randhawa, et al.
Pageof 24